A-Mansia Biotech

About:

A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium.

Website: http://www.a-mansia.com

Twitter/X: a_mansia

Top Investors: Seventure Partners, Innovation Industries, Nivelinvest, Wallonia Regional Government, Fonds Vives II (University of Louvain, UCL)

Description:

A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering the intestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.

Total Funding Amount:

$19.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Louvain-la-neuve, Vlaams-Brabant, Belgium

Founded Date:

2016-01-01

Founders:

Willem M. de Vos

Number of Employees:

11-50

Last Funding Date:

2018-09-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai